Cutting edge Oxford malaria vaccine trial in jeopardy as USAID payments frozen
The Oxford Vaccine Group, led by Prof Andrew Pollard, is renowned for collaborating with Oxford’s Jenner Institute in ...
Jab given to Brits 'could cause serious neurological condition', health experts warn
A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...
The inside story of Britain’s failure to clinch £450mn AstraZeneca deal
How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...
GlobalData on MSN9d
Valneva’s chikungunya vaccine wins UK approval
Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...
GSK launches £2bn buyback on strong HIV and cancer drugs sales
GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines, ...
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...